Publication | Closed Access

Initial Clinical Experience With Regadenoson, a Novel Selective A2AAgonist for Pharmacologic Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging

EngineeringCardiovascular Translational ResearchMedical ImagingCardiovascular DiseaseMyocardial InfarctionBiomedical ImagingCardiac PathologyInitial Clinical ExperiencePublic HealthMedicineMolecular ImagingCardiologyNuclear MedicineNovel Selective A2aagonistRadiologyCardiovascular Imaging